Page last updated: 2024-08-17

levodopa and deferiprone

levodopa has been researched along with deferiprone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B	1
Ayton, S; Behnke, S; Berg, D; Bloem, BR; Bordet, R; Bush, AI; Cabantchik, I; Carpentier, J; Chupin, M; Coelho, MVS; Compta, Y; Corvol, JC; de Bie, RMA; Defebvre, L; Deplanque, D; Devedjian, JC; Devos, D; Dexter, DT; Dodel, R; Duce, JA; Duhamel, A; Dušek, P; Eusebio, A; Ferreira, J; Fradette, C; Gago, M; Garçon, G; Guyon Delannoy, P; Habert, MO; Januario, C; Kuchcinski, G; Kulisevsky, J; Labreuche, J; Leclercq, C; Lehericy, S; Lopes, R; Maetzler, W; Mangin, JF; Marques, AR; Meissner, WG; Moreau, C; Nyholm, D; Ory-Magne, F; Otto, M; Ouk, T; Pavese, N; Pigny, P; Poewe, W; Post, B; Potey, C; Pruvo, JP; Rascol, O; Rolland, AS; Růžička, E; Scherfler, C; Seppi, K; Simonin, O; Spino, M; Thobois, S; Tranchant, C; Tricta, F; Viard, R; Vilas, D; Walter, U; Worth, P	1

Studies

Carrupt, PA; Crivori, P; Cruciani, G; Testa, B

Ayton, S; Behnke, S; Berg, D; Bloem, BR; Bordet, R; Bush, AI; Cabantchik, I; Carpentier, J; Chupin, M; Coelho, MVS; Compta, Y; Corvol, JC; de Bie, RMA; Defebvre, L; Deplanque, D; Devedjian, JC; Devos, D; Dexter, DT; Dodel, R; Duce, JA; Duhamel, A; Dušek, P; Eusebio, A; Ferreira, J; Fradette, C; Gago, M; Garçon, G; Guyon Delannoy, P; Habert, MO; Januario, C; Kuchcinski, G; Kulisevsky, J; Labreuche, J; Leclercq, C; Lehericy, S; Lopes, R; Maetzler, W; Mangin, JF; Marques, AR; Meissner, WG; Moreau, C; Nyholm, D; Ory-Magne, F; Otto, M; Ouk, T; Pavese, N; Pigny, P; Poewe, W; Post, B; Potey, C; Pruvo, JP; Rascol, O; Rolland, AS; Růžička, E; Scherfler, C; Seppi, K; Simonin, O; Spino, M; Thobois, S; Tranchant, C; Tricta, F; Viard, R; Vilas, D; Walter, U; Worth, P

Trials

1 trial(s) available for levodopa and deferiprone

Article	Year
Trial of Deferiprone in Parkinson's Disease. The New England journal of medicine, 2022, 12-01, Volume: 387, Issue:22 Topics: Administration, Oral; Antiparkinson Agents; Brain; Brain Chemistry; Deferiprone; Disease Progression; Dopamine Agents; Double-Blind Method; Humans; Iron; Iron Chelating Agents; Levodopa; Neutropenia; Parkinson Disease; Substantia Nigra	2022

Other Studies

1 other study(ies) available for levodopa and deferiprone

Article	Year
Predicting blood-brain barrier permeation from three-dimensional molecular structure. Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11 Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000